Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H46FN5O9S |
InChIKeyKNRSXDLSSCIKMT-HTFIMNNOSA-N |
CAS Registry1285533-27-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | - | - | |
Hepatitis C | Preclinical | - | - | |
Hepatitis C | Preclinical | - | - | |
Hepatitis C | Preclinical | - | - |